"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

NCT00072683 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremias
Water Intoxication
Inappropriate ADH Syndrome
Water-Electrolyte Imbalances

Interventions

DRUG: tolvaptan

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]